IU Health had one of its most profitable years ever in 2014, as it cut staff, boosted its physician office visits and improved bill collections. But it is still hoarding cash to be ready for future cuts in reimbursement as well as future building projects.
The main driver of colleges getting out of the insurance business is a provision in the Affordable Care Act that prevents students from using premium tax subsidies to purchase insurance from their college or university.
After 15 years on the air, "Sound Medicine" will broadcast its last new episode on April 26. The Indiana University School of Medicine, the show's primary funder, wants to change the direction of its marketing.
Think we’re almost done with changes from Obamacare? Think again. Things won’t settle down any sooner than 2017, and they could actually get even wilder after that.
Nurses at Indiana University Health’s downtown hospitals are moving quickly to form a union in a bid they say is designed to improve their own working conditions and pay and to improve care for patients.
President Barack Obama is enlisting private companies into his drive to change the way the U.S. pays its medical bills, including insurers Anthem Inc. and Cigna Inc. and casino chain Caesars Entertainment Corp.
New research from the Mayo Clinic is bringing back a long-running debate over whether drug companies like Eli Lilly and Biogen are focusing on the right target in developing therapies to treat the disease.
Terminally ill patients in Indiana who have run out of FDA-approved options can now turn to treatments and medicines in the testing phase.
A proposal aimed at giving terminally ill patients in Indiana easier access to experimental drugs not yet on pharmacy shelve is about to become law.
The fact that Assembly Biosciences Inc. and AgeneBio now list New York and Baltimore, respectively, as their headquarters cities doesn’t hurt Indiana and could help the state, says David Johnson, CEO of BioCrossroads.
The top five executives at Eli Lilly and Co. took home 5 percent to 10 percent less in cash, stock and perks last year than the year before, according to a Monday securities filing.
The Indiana Behavioral Health and Human Services Board voted Monday to suspend clinical social worker Robin Paul's license for 90 days.
The results of an experimental drug for Alzheimer’s disease provide the best evidence so far that the memory-robbing condition is caused by an errant protein in the brain. Drugmakers including Eli Lilly have been concentrating their Alzheimer’s research on that area.
A proposal to give terminally ill patients easier access to experimental drugs not yet on pharmacy shelves has been forwarded to Gov. Mike Pence for his signature.
New research shows patients lose trust and confidence in doctors that take money for travel, but like it when their doctors are paid as consultants during the development of new products.
A jury found in favor of Billie Jo Sayers on Monday in her lawsuit against IU Health Ball Memorial Hospital in Muncie.
Indiana would have a three-year moratorium on construction of most new nursing homes under a proposal the state House narrowly approved Tuesday.
The Indiana Senate has approved a measure that would allow terminally ill patients to use experimental drugs that are not yet on pharmacy shelves.
IU Health has named Dr. Paul Haut to replace CEO Jeff Sperring when he leaves on April 17 while the hospital searches for a permanent replacement.
Major drugmakers—including Indianapolis-based Eli Lilly and Co.—the British government and a top Alzheimer's research charity are pooling more than $100 million to create a global fund to accelerate efforts to find a treatment or cure.
